Halozyme Therapeutics Inc. buy Morgan Stanley
Start price
18.08.25
/
50%
€58.38
Target price
18.08.26
€68.36
Performance (%)
-2.57%
Price
09:30
€56.88
Summary
This prediction is currently active. With a performance of -2.57%, the BUY prediction for Halozyme Therapeutics Inc. by Morgan_Stanley is down slightly. This prediction currently runs until 18.08.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Halozyme Therapeutics Inc. | -1.359% | -1.359% |
| iShares Core DAX® | -6.016% | -4.595% |
| iShares Nasdaq 100 | 0.511% | 0.164% |
| iShares Nikkei 225® | -7.156% | -2.215% |
| iShares S&P 500 | -0.257% | -0.841% |
Comments by Morgan_Stanley for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target raised by analysts at Morgan Stanley from $75.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for HALO provided by MarketBeat
Stopped prediction by Morgan_Stanley for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€57.80
20.10.25
20.10.25
€67.75
20.10.26
20.10.26
-1.59%
09:30
09:30
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€54.00
06.08.25
06.08.25
€64.83
06.08.26
06.08.26
5.33%
09:30
09:30
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.79
07.08.24
07.08.24
€58.59
07.08.25
07.08.25
6.69%
08.08.25
08.08.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€34.03
26.12.23
26.12.23
€53.50
26.12.24
26.12.24
34.94%
27.12.24
27.12.24
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€40.11
10.08.23
10.08.23
€55.35
10.08.24
10.08.24
26.55%
11.08.24
11.08.24
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€42.50
06.03.23
06.03.23
€60.06
06.03.24
06.03.24
-10.61%
07.03.24
07.03.24